Position in TNYA
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$7,390
+$470 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 101 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quadcap Wealth Management, LLC holds $2,649,115 across 9 Biotechnology names. TNYA ranks #9 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,895 | $941,303 | |
| 2 | EXEL |
Exelixis, Inc.
|
9,961 | $541,978 | |
| 3 | GPCR |
Structure Therapeutics Inc.
|
7,635 | $409,770 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
4,747 | $258,901 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
5,758 | $224,619 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
682 | $205,302 | |
| 7 | ANVS |
Annovis Bio, Inc.
|
16,110 | $29,964 | |
| 8 | OVID |
Ovid Therapeutics Inc.
|
11,111 | $29,888 |
All Filings in TNYA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,390 | 10,000 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $6,920 | 10,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,120 | 10,000 | Shares | Sole | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||